Discover the Science of Health
Today is World Vegan Day, an annual event celebrated on November 1st. World Vegan Day is an opportunity to promote the benefits of a vegan diet (a vegan diet involves eating only plant-based foods) and veganism in general. People observing the day celebrate the benefits of veganism for humans, animals and the environment. The day also kicks off World Vegan Month.
New research suggests that the intensity of exercise might be more important than the quantity in helping to prevent death from heart disease and other causes.
In a study presented last week at the European Society of Cardiology Congress 2011, scientists described new research that examined the relationship between exercise duration, exercise intensity, and total risk of death [1]. Lead researcher Peter Schnohr of Copenhagen, Denmark explained that both male and female cyclists had a decreased total risk of death if they cycled vigorously (by their own perception), but that cycling duration didn’t show a similar protective effect.
Statins are a class of drugs that lower cholesterol and thereby reduce the risk of heart disease and stroke. They work by preventing the synthesis of low-density lipoprotein (LDL or “bad cholesterol”) in the liver and promoting its clearance from the blood. They are the most effective cholesterol-lowering drugs currently available and are the cornerstone of the National Heart, Lung, and Blood Institute’s National Cholesterol Education Program (NCEP) treatment guidelines.
The NCEP recommends a “treat-to-target” strategy, in which patients are given specific statin doses to achieve a desired level of LDL cholesterol in the blood. In this case, low LDL cholesterol is the “target.” Yet some physicians are questioning whether treating to any target is the best approach to fighting disease. A recent study in the Annals of Internal Medicine suggests that “tailored treatment”, an approach attempts to practice personalized medicine by estimating three factors, is more effective than a treat-to-target strategy [1].
A study published in the Archives of Internal Medicine this week concluded that garlic supplementation does not improve cholesterol profiles in people with moderately high levels of LDL cholesterol (defined here as a fasting plasma LDL cholesterol concentration of 130 to 190 mg/dL, a triglyceride level less than 250 mg/dL and body mass index, calculated as weight in kilograms divided by height in meters squared, of 19 to 30). The study is the first independent, long-term assessment of raw garlic and two popular garlic supplements. Raw garlic (4g/day for 6 months), powdered garlic and aged garlic extract supplement were tested on 192 adults with moderately high levels of LDL cholesterol. None of the garlic forms studied had statistically or clinically significant effects on LDL cholesterol or other plasmid lipid concentrations. The results contradict other recent findings suggesting that garlic may be beneficial in heart health by reducing moderately high levels of LDL cholesterol in adults [1-2].
